TCT-31 Impact of Strut Thickness on Short-Term Healing Response after Bioresorbable Scaffold Implantation: Serial OCT Evaluation of Novel Thin Strut Sirolimus Eluting BRS Versus Thick Strut Everolimus Eluting BRS in Porcine Coronary Arteries

TCT-31 Impact of Strut Thickness on Short-Term Healing Response after Bioresorbable Scaffold Implantation: Serial OCT Evaluation of Novel Thin Strut Sirolimus Eluting BRS Versus Thick Strut Everolimus Eluting BRS in Porcine Coronary Arteries

Background The most widely commercially available bioresorbable scaffold (BRS) Absorb has strut thickness of 165 microns. [...]it has potential for higher thrombogenicity, especially in the early phase of vessel healing.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2016-11, Vol.68 (18), p.B13-B13
Hauptverfasser: Gasior, Pawel, Cheng, Yanping, Xia, Jinggang, Valencia, Andres, Estrada, Alex, McGregor, Jenn, Ramzipoor, Kamal, Lee, Chang, Conditt, Gerard, Kaluza, Greg, Granada, Juan
Format: Artikel
Sprache:eng
Schlagworte:
Acquisitions & mergers
Cardiology
Cardiovascular
Coronary vessels
Internal Medicine
Stents
Veins & arteries
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background The most widely commercially available bioresorbable scaffold (BRS) Absorb has strut thickness of 165 microns. [...]it has potential for higher thrombogenicity, especially in the early phase of vessel healing.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2016.09.052